The potential effect of an HIV/AIDS vaccine in South Africa
| dc.contributor.author | Dorrington, R E | |
| dc.contributor.author | Johnson, L F | |
| dc.date.accessioned | 2017-05-25T12:18:56Z | |
| dc.date.available | 2017-05-25T12:18:56Z | |
| dc.date.issued | 2007 | |
| dc.date.updated | 2016-01-08T10:05:58Z | |
| dc.description.abstract | This paper presents a model for assessing the potential effect of an HIV/AIDS vaccine in South Africa, and for calculating the amount of vaccine that would be required. A number of different hypothetical vaccine profiles and vaccine distribution strategies are considered. Results suggest that a sterilising vaccine could reduce the HIV incidence between 2015 and 2025 by up to 50%, while a disease modifying vaccine would be unlikely to reduce HIV incidence by more than a third. The effect on AIDS mortality over the same period would be substantially smaller, and it is unlikely that any preventive vaccine would reduce AIDS mortality by more than 10% between 2015 and 2025. | |
| dc.identifier.apacitation | Dorrington, R. E., & Johnson, L. F. (2007). The potential effect of an HIV/AIDS vaccine in South Africa. <i>South African Actuarial Journal</i>, http://hdl.handle.net/11427/24410 | en_ZA |
| dc.identifier.chicagocitation | Dorrington, R E, and L F Johnson "The potential effect of an HIV/AIDS vaccine in South Africa." <i>South African Actuarial Journal</i> (2007) http://hdl.handle.net/11427/24410 | en_ZA |
| dc.identifier.citation | Johnson, L. F., & Dorrington, R. E. (2007). The potential effect of an HIV/AIDS vaccine in South Africa. South African Actuarial Journal, 7(1), 49-72. | |
| dc.identifier.ris | TY - Journal Article AU - Dorrington, R E AU - Johnson, L F AB - This paper presents a model for assessing the potential effect of an HIV/AIDS vaccine in South Africa, and for calculating the amount of vaccine that would be required. A number of different hypothetical vaccine profiles and vaccine distribution strategies are considered. Results suggest that a sterilising vaccine could reduce the HIV incidence between 2015 and 2025 by up to 50%, while a disease modifying vaccine would be unlikely to reduce HIV incidence by more than a third. The effect on AIDS mortality over the same period would be substantially smaller, and it is unlikely that any preventive vaccine would reduce AIDS mortality by more than 10% between 2015 and 2025. DA - 2007 DB - OpenUCT DP - University of Cape Town J1 - South African Actuarial Journal LK - https://open.uct.ac.za PB - University of Cape Town PY - 2007 T1 - The potential effect of an HIV/AIDS vaccine in South Africa TI - The potential effect of an HIV/AIDS vaccine in South Africa UR - http://hdl.handle.net/11427/24410 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/24410 | |
| dc.identifier.vancouvercitation | Dorrington RE, Johnson LF. The potential effect of an HIV/AIDS vaccine in South Africa. South African Actuarial Journal. 2007; http://hdl.handle.net/11427/24410. | en_ZA |
| dc.language.iso | eng | |
| dc.publisher.department | Centre for Actuarial Research (CARE) | en_ZA |
| dc.publisher.faculty | Faculty of Commerce | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.source | South African Actuarial Journal | |
| dc.source.uri | http://www.actuarialsociety.org.za/Professionalresources/SAActuarialJournal.aspx | |
| dc.title | The potential effect of an HIV/AIDS vaccine in South Africa | |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |